Suppr超能文献

极低热量饮食。美国国立卫生研究院肥胖预防与治疗国家特别工作组

Very low-calorie diets. National Task Force on the Prevention and Treatment of Obesity, National Institutes of Health.

出版信息

JAMA. 1993 Aug 25;270(8):967-74.

PMID:8345648
Abstract

OBJECTIVE

To provide an overview of the published scientific information on the safety and efficacy of very low-calorie diets (VLCDs) and to provide rational recommendations for their use.

DATA SOURCES AND EXTRACTION

Original reports obtained through a MEDLINE search for 1966 through 1992 on VLCDs or reducing diets plus obesity, supplemented by a manual search of bibliographies and the opinions of experts in the field of nutrition and weight loss therapy for obesity. Only studies of humans were cited.

DATA SYNTHESIS

Current VLCDs are usually provided in the context of comprehensive treatment programs, during which usual food intake is completely replaced by specific foods or liquid formulas containing 3350 kJ/d (800 kcal/d) or less. Weight loss on VLCDs averages 1.5 to 2.5 kg/wk; total loss after 12 to 16 weeks averages 20 kg. These results are superior to standard low-calorie diets of 5020 kJ/d (1200 kcal/d), which lead to weight losses of 0.4 to 0.5 kg/wk and an average total loss of only 6 to 8 kg. There is little evidence that intakes of less than 3350 kJ/d (800 kcal/d) result in better weight losses than 3350 kJ. Intake of at least 1 g/kg of ideal body weight per day of protein of high biologic value appears to be important in helping to preserve lean body mass. Serious complications of modern VLCDs are unusual, cholelithiasis being most common.

CONCLUSIONS

Current VLCDs are generally safe when used under proper medical supervision in moderately and severely obese patients (body mass index [weight in kilograms divided by height in meters squared] > 30) and are usually effective in promoting significant short-term weight loss, with concomitant improvement in obesity-related conditions. Long-term maintenance of weight lost with VLCDs is not very satisfactory and is no better than with other forms of obesity treatment. Incorporation of behavioral therapy and physical activity in VLCD treatment programs seems to improve maintenance.

摘要

目的

综述已发表的关于极低热量饮食(VLCDs)安全性和有效性的科学信息,并为其应用提供合理建议。

数据来源与提取

通过MEDLINE检索1966年至1992年关于VLCDs或减肥饮食与肥胖的原始报告,并辅以人工检索参考文献以及营养与肥胖减肥治疗领域专家的意见。仅引用了人体研究。

数据综合

目前的VLCDs通常在综合治疗方案中使用,在此期间,通常的食物摄入量完全被特定食物或含能量3350千焦/天(800千卡/天)或更低的液体配方所替代。VLCDs的体重减轻平均为每周1.5至2.5千克;12至16周后的总体重减轻平均为20千克。这些结果优于标准的5020千焦/天(1200千卡/天)低热量饮食,后者导致每周体重减轻0.4至0.5千克,平均总体重减轻仅6至8千克。几乎没有证据表明摄入量低于3350千焦/天(800千卡/天)比3350千焦能带来更好的体重减轻效果。每天摄入至少1克/千克理想体重的高生物价值蛋白质,对于帮助维持瘦体重似乎很重要。现代VLCDs的严重并发症并不常见,胆石症最为常见。

结论

目前的VLCDs在适当的医学监督下用于中度和重度肥胖患者(体重指数[体重千克数除以身高米数的平方]>30)时通常是安全的,并且通常能有效促进显著的短期体重减轻,同时改善与肥胖相关的状况。用VLCDs减轻体重后的长期维持效果不太令人满意,并不优于其他形式的肥胖治疗方法。在VLCD治疗方案中纳入行为疗法和体育活动似乎有助于改善体重维持情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验